EDTUTC-4 New YorkLog in Sign up

GMAB
Genmab A/S ADS
stockNASDAQADR

At CloseOct 2, 2026 3:59:58 PM EDT

34.74USD+0.564%(+0.19)5,436,431

Pre-marketOct 5, 2026 8:56:30 AM EDT

34.70USD-0.144%(-0.05)

After-hoursOct 2, 2026 4:49:30 PM EDT

34.81USD+0.187%(+0.06)

GMAB News

Day breaks

12:01 PM EDTWilliam Blair refreshes its analyst conviction list ·

Seeking Alpha

10:57 AM EDTTop 20 Nasdaq-100 names powering the NDX’s 2026 record run ·

Seeking Alpha

10:49 AM EDTGenmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2026 Transcript ·

Seeking Alpha

05:01 PM EDTGenmab A/S (GMAB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

08:30 PM EDTMonoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider ·

GlobeNewswire Inc.

02:44 PM EDTCapital Increase in Genmab as a Result of Employee Warrant Exercise ·

GlobeNewswire Inc.

01:00 PM EDTAdvanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight ·

GlobeNewswire Inc.

09:00 AM EDTGenmab to Participate in Upcoming Investor Conferences ·

GlobeNewswire Inc.